# Owner decision, independent review and delivery receipt

**Issue [#120](https://github.com/abuhmaid28/egyhealth360/issues/120) · docs/read-only · STOP for Product Owner findings review.** Read [root cause/evidence](ROOT_CAUSE_AND_EVIDENCE.md) and [options, future regression and rollback](OPTIONS_REGRESSION_AND_ROLLBACK.md). [Authorization6797946436](https://github.com/abuhmaid28/egyhealth360/pull/119#issuecomment-6797946436) grants no remediation, topology selection, severity change, runtime execution, merge or deployment.

## 1. Disposition and GO/NO-GO

**F06 stays P2.** Source and accepted historical E13 support a high-confidence bounded explanation: the default built loopback upstream is used from web's container namespace rather than API's separate namespace. This review presents no new runtime failure, auth breach, hosted outage or mandatory-path impact evidence. No severity change is justified by re-reading the same failure.

| Decision boundary | Result and evidence needed next |
| --- | --- |
| Review this report | **GO for owner consideration** of the source-grounded finding and fair options, subject to actual final docs CI and independent delivery verification recorded in PR metadata. Docs Green is not runtime health. |
| Call default Compose Live E2E safe / F06 closed | **NO-GO**: historical web rewrite500 remains; root/API200 and #119 frontend CI do not cover the missing hop. Require exact repaired default artifact/topology R01–R11/R13–R14, any separately required R12 scope, and owner closure disposition. |
| Call B a currently validated substitute | **NO-GO now**: existing source/E12 shows feasibility, not fresh candidate/environment proof. Only a separately approved and directly validated B may satisfy a named alternative acceptance path; Compose F06 remains OPEN. |
| Choose, build, fix, retest or deploy either topology | **NO-GO under this authorization**. Owner separately selects mandatory target and approves exact files, test commands/permissions, safe resources and rollback. No remediation issue/PR is created here. |
| Future P1 recommendation | Only if the owner mandates an essential Live Compose path, a new authorized execution demonstrates it blocked and no accepted validated alternative satisfies that requirement. Record requirement/failure/impact, request separately approved severity disposition and a bounded Stage1.5 proposal before major phase progression. Do not silently reclassify. |
| Stay P2 | Defect remains scoped to a currently unselected/optional default local topology, with no newly demonstrated mandatory-path impact. An approved alternative may unblock its own path but never erases F06. Untested domains still cannot be declared free of P0/P1. |

## 2. Exact next-owner decision package

The requested decision **now** is accept/revise/defer these findings. Acceptance does not select a topology or authorize execution. The next record must answer all of the following before any remediation task:

1. **Mandatory path:** default Compose, isolated host B1, another explicitly specified proxy, or both? Is the graduation demonstration required to be Live, or expressly labelled synthetic Demo? A static/controlled HTTP screenshot cannot satisfy promised real Live evidence; no automatic Live→Demo recovery.
2. **Candidate/provenance:** exact source/base and environment. Main `5355ae5b12bb86ed2c05f70fcadd77eadcd7bde3` and bounded unmerged #119 `4270a682ae3973385ca2c4c86f587d1ca9f1ca03` are different candidates. Owner must separately authorize any combined UI+transport composition; keep #119 unchanged now. Define image/build-origin/route-manifest or host-process attribution and exact browser origin.
3. **File and execution allowlist:** choose/shrink the precise prospective packet in [options section5](OPTIONS_REGRESSION_AND_ROLLBACK.md#5-exact-future-executionharness-ownership-and-ci-proposal). A1 build-origin changes are distinct from a larger runtime proxy design. Separately authorize builds/processes, disposable schema/fixtures, auth/read regression and any named clinical/fault/replay operations; no blanket permission from “synthetic.” Stop if an additional file or policy decision is needed.
4. **Safety and independent review:** require exact cookie modes/Origin/CSRF, Patient own/Doctor current authority, private-source/count/DOM/AX suppression, no-store, Live isolation and no automatic clinical retry in R01–R14. Require architecture/build/DevOps and clinical/privacy reviewers against the actual final candidate. No CORS/CSRF or authority weakening to make a topology pass.
5. **Budget/rollback:** existing free infrastructure only; assign finite Actions/runtime budget and resource owner, not an assumed free quota. Approve exact image/config/process rollback and safe command/unsaved/uncertainty boundary. A known-bad baseline is not safe Live recovery.
6. **Closure definition:** declare F06 CLOSED only after independently attributed default-Compose web→API health succeeds, same-origin auth/session/cookie/CSRF/clinical read negatives pass, required affected exact-head CI succeeds, rollback/isolation evidence is reviewed and owner explicitly dispositions the finding. A successful B-only run is **alternative-path validated / F06 still OPEN**; public health200, a green UI job or documentation acceptance alone is insufficient.

## 3. Preserved health and product gates

This table summarizes influence, not new findings or authorized fixes. [Pinned audit ledger](https://github.com/abuhmaid28/egyhealth360/blob/1dda926d0bedfad9fa0ccb69c013aa8263742386/docs/health-audit-2026-11/HEALTH_FINDINGS.md) remains authoritative evidence with its execution limits.

| Gate / retained disposition | Limit retained for later work |
| --- | --- |
| F01 P2 dependency advisories | Historical nonempty moderate/low reports with no high/critical at audit time; exploitability unverified. No audit/upgrade executed here; new complete graph/security/license disposition before release. |
| F02 P2 + U03 BLOCKED hosted provenance/operations | Historical hosted frontend/API/main differ; active DB/ledger/grants/TLS/backups/restore/image/quota/rollback unproved. No current hosted health, outage, parity or readiness claim; no hosted reads/transactions now. |
| F03 P2 critical Arabic fallback | Missing critical-key behavior unresolved, no new missing consequential key demonstrated. Future safety-copy contract/retests must remain separately scoped; no i18n fix under topology work. |
| F04 P2 initial EN/LTR → AR/RTL | Initial markup/effect order debt remains; no proven universal visible flash/AT result and no SSR/theme patch here. A good hydrated screenshot does not close it. |
| F05 P3 I2 prior-target key conflict | Historical no payload/write; desired privacy/replay denial interpretation remains owner/security OPEN. Do not silently replace I2 semantics with I3's stronger rule or call this an established breach. |
| F06 P2 default Compose route | No fix, fresh build/reproduction, selected topology or closure. Local failure does not imply hosted failure. |
| U01 UNVERIFIED / U02 UNVERIFIED | Older I2 disconnect cleanup not reproduced; effective ingress/login-abuse budget unproved. New fault/load experiments need separate approval; healthy concurrency/auth examples cannot close them. |
| U04 / staff capabilities / Final DS | Pharmacy backend≠Live staff UI; Lab backend/results/Live remain FUTURE; Admin internal foundations≠public management. Screenshots confer no authority. Theme T1 direction unimplemented; final semantic tokens/DS/rollout remain owner-gated. |
| CD07 Patient Detail | #119 accepted Patient overview12h only; **V1 Patient Booking Detail remains24h as a deferred V2 gap**. Future V2 overview **and detail** require localized12h periods; professional/consequential timestamps remain24h with exact IANA/date-specific offsets, fold/midnight/precision. No display/parser/eligibility change here. |
| AP03 / AP05 OPEN | Physical browsers/devices/PWA/OS text, real AT/native400%/print and five Type3 PDF warnings remain; font OFLs do not establish artwork creator/derivative/trademark rights. No applicable distribution/legal/clinical certification. |

All backend boundaries persist: current assignment, not booking/role/membership/authorship alone, grants clinical authority; Patient own permitted data; author-private notes distinct from explicit summary/follow-up release and irreversible close. ADMIN has no clinical/impersonation/assignment-creation/break-glass shortcut. Exact routed staff authority and D36 independence remain. Preserve wrong-patient payload/ID/link/count suppression, current-authority replay, immutable history, server actor/time, canonical operation keys/atomic audits and no automatic clinical retries. Missing evidence remains uncertain; no diagnosis/dose/rule inference is introduced.

## 4. Independent criticism and residual disagreements

Two distinct read-only agent roles independently examined sources/contracts rather than accepting the author's causality summary. They did not execute runtime/build/network/clinical tests, modify source or certify medical/legal/security readiness. Both roles completed independent content review of all three reports and the pointer diffs, with no remaining blocking issue. Content verdicts are bounded to this documentation; final committed-head/CI verification is recorded separately in the PR receipt.

| Role | Independent critical contribution / disposition |
| --- | --- |
| `f120_arch_devops` — architecture/build/DevOps | Confirmed build-origin/default loopback chain and actual CI omission. Corrected “separate networks” to shared Compose network/separate loopback namespaces; identified `.dockerignore`, shared-image attribution risk, write-capable existing host harness and mobile forwarded-origin caveat. Required explicit generated-artifact provenance and no universal Next-runtime-env claim. **Content PASS for bounded review** after incorporation; generated-file size/hash independently matched. Final committed-head/delivery verification belongs in PR receipt. |
| `f120_security_clinical` — security/clinical/privacy | Independently derived method-specific login/logout/GET semantics, canonical cookie modes, session-before-CSRF status ordering, exact Origin versus Host and browser-CORS versus raw-header evidence. Flagged auth/fixture writes, source/current-grant versus logistical booking access, unknown-key rollback and main versus #119 attribution. **Content PASS for bounded review** after incorporation; permission labels clarified as E0–E3, distinct from severity. Final committed-head/delivery verification belongs in PR receipt. |

**Disagreements/unknowns retained, not voted away:** final mandatory topology and A/B tradeoffs require owner choice; actual Next build/start variability and effective proxy cookie forwarding require later tests; F05 intended I2 privacy semantics remain unresolved; quota/cost estimates and future host/Compose/hosted parity are unverified. No review agreement supplies missing runtime evidence, selects a topology or changes F06 severity.

## 5. Exact changed scope, preservation and validation receipt

Only five Markdown paths may differ from freshly verified main:

1. NEW `docs/f06-topology-review/ROOT_CAUSE_AND_EVIDENCE.md`
2. NEW `docs/f06-topology-review/OPTIONS_REGRESSION_AND_ROLLBACK.md`
3. NEW `docs/f06-topology-review/OWNER_DECISION_AND_INDEPENDENT_REVIEW.md`
4. `docs/CURRENT_STATUS.md` — minimal current review pointer, retaining historical context.
5. `docs/SOURCE_OF_TRUTH.md` — required classification of these three reports.

Exhaustive base/final tree mode/type/blob comparison must retain all1423 baseline paths; only the two pointer exceptions may differ, leaving1421 identical, plus3 new docs. Runtime, Docker/Compose/Next/build config, API/auth/session, tests/CI/dependencies, DB/schema/all22 migrations/OpenAPI, clinical/security contracts, fonts/logos/screenshots/protected historical evidence remain identical. Source PR #119 must keep exact head/Draft/Open/Unmerged/auto-merge OFF and unchanged contents; #115/#117 pins remain independent references. No historical report tree or generated manifest is copied into this delivery.

Permitted new validation: dependency-free existing `node --test tests/ci/*.test.mjs`, maintained/changed-Markdown reference/classification/anchor checks using actual base/head event, complete-range whitespace and exact path/mode/blob preservation; external pinned file/line targets checked against Git objects. Those governance tests create only disposable test histories, not application/DB resources. No build, dependency install/audit, Docker invocation, service/browser/health/auth probe, fixture setup, clinical write, migration, hosted operation, secret access or rollback rehearsal occurred.

**Exact-final-head remote receipt is recorded in this Draft PR's description after the final commit**, avoiding a self-referential head hash or post-CI source commit. Verify source head/base/sole parent, event/attempt/conclusion, actual classifier and every job/log, clean local tree and PR state. Expected unchanged policy for these Markdown paths is DOCS_GOVERNANCE/full=false: select classify/docs-check/validate; omit frontend-check/backend-check/postgres/docker-runtime/dependency-audit. This expectation is not a PASS. Final handoff must report all selected successes, intentional skips and failures/cancellations honestly; skipped heavy tests never become runtime health. No full dispatch, rerun, waiver or policy edit is planned.

**STOP:** owner reviews findings/limits first, then separately chooses any mandatory topology and authorizes exact remediation/retest scope. Leave this and #119 Draft/Open/Unmerged/auto-merge OFF. No merge, deployment, promotion, release approval, Final Design System decision, paid service or automatic follow-on task.
